These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
430 related articles for article (PubMed ID: 34478904)
1. Effectiveness of MicroShunt in Patients with Primary Open-Angle and Pseudoexfoliative Glaucoma: A Retrospective European Multicenter Study. Fea AM; Laffi GL; Martini E; Economou MA; Caselgrandi P; Sacchi M; Au L Ophthalmol Glaucoma; 2022; 5(2):210-218. PubMed ID: 34478904 [TBL] [Abstract][Full Text] [Related]
5. Safety and Effectiveness of the PRESERFLO® MicroShunt in Primary Open-Angle Glaucoma: Results from a 2-Year Multicenter Study. Beckers HJM; Aptel F; Webers CAB; Bluwol E; Martínez-de-la-Casa JM; García-Feijoó J; Lachkar Y; Méndez-Hernández CD; Riss I; Shao H; Pinchuk L; Angeles R; Sadruddin O; Shaarawy TM Ophthalmol Glaucoma; 2022; 5(2):195-209. PubMed ID: 34329772 [TBL] [Abstract][Full Text] [Related]
6. Ab Externo SIBS Microshunt with Mitomycin C for Open-Angle Glaucoma: Three-Year Results as a Primary Surgical Intervention. Armstrong JJ; De Francesco T; Ma J; Schlenker MB; Ahmed IIK Ophthalmol Glaucoma; 2023; 6(5):480-492. PubMed ID: 37044278 [TBL] [Abstract][Full Text] [Related]
7. Ab interno gel implant in patients with primary open angle glaucoma and pseudoexfoliation glaucoma. Hengerer FH; Auffarth GU; Yildirim TM; Conrad-Hengerer I BMC Ophthalmol; 2018 Dec; 18(1):339. PubMed ID: 30587169 [TBL] [Abstract][Full Text] [Related]
9. One-year outcomes of microshunt implantation in pseudoexfoliation glaucoma. Nobl M; Freissinger S; Kassumeh S; Priglinger S; Mackert MJ PLoS One; 2021; 16(8):e0256670. PubMed ID: 34449795 [TBL] [Abstract][Full Text] [Related]
10. One-year follow-up of the XEN® implant with mitomycin-C in pseudoexfoliative glaucoma patients. Ibáñez-Muñoz A; Soto-Biforcos VS; Chacón-González M; Rúa-Galisteo O; Arrieta-Los Santos A; Lizuain-Abadía ME; Del Río Mayor JL Eur J Ophthalmol; 2019 May; 29(3):309-314. PubMed ID: 30145910 [TBL] [Abstract][Full Text] [Related]
11. Efficacy and Safety of the Preserflo Microshunt With Mitomycin C for the Treatment of Open Angle Glaucoma. Ibarz Barberá M; Martínez-Galdón F; Caballero-Magro E; Rodríguez-Piñero M; Tañá-Rivero P J Glaucoma; 2022 Jul; 31(7):557-566. PubMed ID: 35583510 [TBL] [Abstract][Full Text] [Related]
12. Two-year outcomes of minimally invasive XEN Gel Stent implantation in primary open-angle and pseudoexfoliation glaucoma. Rauchegger T; Angermann R; Willeit P; Schmid E; Teuchner B Acta Ophthalmol; 2021 Jun; 99(4):369-375. PubMed ID: 32996702 [TBL] [Abstract][Full Text] [Related]
13. A 2-Year, Single-Center Study to Assess the Safety and Effectiveness of the MicroShunt in Primary Open-Angle Glaucoma. Riss I Ophthalmic Res; 2023; 66(1):206-217. PubMed ID: 36137526 [TBL] [Abstract][Full Text] [Related]
14. Outcomes of Prolene Gonioscopy Assisted Transluminal Trabeculotomy in Primary Open Angle Glaucoma and Pseudoexfoliation Glaucoma: A Comparative Study. Aktas Z; Ozdemir Zeydanli E; Uysal BS; Yigiter A J Glaucoma; 2022 Sep; 31(9):751-756. PubMed ID: 35696703 [TBL] [Abstract][Full Text] [Related]
15. Long-term Outcomes of PreserFlo MicroShunt versus XEN45 Gel Stent in Open-Angle Glaucoma. Nobl M; Freissinger S; Rudolph K; Vounotrypidis E; Kassumeh S; Priglinger S; Mackert MJ Klin Monbl Augenheilkd; 2024 Jul; 241(7):805-812. PubMed ID: 37673088 [TBL] [Abstract][Full Text] [Related]
16. Intermediate Outcomes of a Novel Standalone Ab Externo SIBS Microshunt With Mitomycin C. Schlenker MB; Durr GM; Michaelov E; Ahmed IIK Am J Ophthalmol; 2020 Jul; 215():141-153. PubMed ID: 32173344 [TBL] [Abstract][Full Text] [Related]
18. Ab externo implantation of the MicroShunt, a poly (styrene- Sadruddin O; Pinchuk L; Angeles R; Palmberg P Eye Vis (Lond); 2019; 6():36. PubMed ID: 31807606 [TBL] [Abstract][Full Text] [Related]
19. One-year outcomes of stand-alone ab externo SIBS microshunt implantation in refractory glaucoma. Durr GM; Schlenker MB; Samet S; Ahmed IIK Br J Ophthalmol; 2022 Jan; 106(1):71-79. PubMed ID: 33097520 [TBL] [Abstract][Full Text] [Related]
20. Preliminary results of Preserflo Microshunt versus Preserflo Microshunt and Ologen implantation. Vastardis I; Fili S; Perdikakis G; Kontopoulou K; Balidis M; Gatzioufas Z; Kohlhaas M Eye Vis (Lond); 2021 Sep; 8(1):33. PubMed ID: 34479641 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]